BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2013
View Archived Issues
Investigators report discovery of novel allosteric MEK inhibitor CInQ-03
Read More
Phase I/II results presented for the long-acting rhGH in children
Read More
Moffitt Cancer Center forms strategic partnership with Advinus Therapeutics
Read More
Horizon Discovery and Hisun enter agreement
Read More
Researchers present a novel mouse model of human myelofibrosis
Read More
Belrose Pharma acquires Enzon's advanced drug formulation technology
Read More
Vivus study shows avanafil is effective for sexual activity within 15 minutes
Read More
QGC-001 is well tolerated at doses of up to 1250 mg
Read More
Results announced from first pivotal trial of ALK's allergy immunotherapy tablet
Read More
Application seeking approval of tofogliflozin submitted in Japan
Read More
MC1R SNPs found to be associated with the severity of RLS
Read More
BerGenBio begins phase I trial of BGB-324
Read More
Pharmaxis enrolls first subject into pediatric trial evaluating Bronchitol in cystic fibrosis
Read More
BioSante Pharmaceuticals and ANI Pharmaceuticals complete merger
Read More
PsiOxus Therapeutics begins second study of ColoAd1 vaccine
Read More
Intezyne Technologies acquires Niiki Pharma
Read More
Novel apoptosis inducers presented by researchers in Barcelona
Read More
Novartis prepares novel HDAC4 inhibitors
Read More
Paladin's NDA for Impavido granted priority review
Read More
ChemoCentryx synthesizes new chemokine receptor antagonists
Read More
Boehringer Ingelheim presents novel agents for diabetes and obesity
Read More
Volibris tablets granted new Japanese orphan drug designation
Read More
OncoSec completes enrollment in phase II ImmunoPulse trial in metastatic melanoma
Read More
Merck Serono initiates phase I study of ALX-0761
Read More
Evoltra launched in Japan
Read More
A new university spin-out raises funding to develop new anticoagulant drug
Read More
